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General Procedure. 
All reactions were performed in a dry nitrogen atmosphere using standard Schlenk techniques or 
in the glove box.  
Anhydrous solvents over molecular sieve purchased from Fluka were systematically used. 
Amines (generally > 99%) were used as provided by Aldrich, Fluka, Acros. Triethylamine was 
stored over KOH pellets. (R)-O,O’-(1,1’-Dinaphthyl-2,2’-diyl)-phosphorus chloride was prepared 
according to a published procedure.1 Rh(COD)2BF4 was provided by OMG. The hydrogenation 
substrates, N-acetyl-dehydrophenylalanine methyl ester (1) and 3-acetylamino-but-2-enoic acid 
methyl ester (2) were synthesized following published procedures.2 
The library was synthesized using a Zinsser Lissy liquid handling robot equipped with 4 probes 
and placed inside a glove box. Whatman PKP 2mL 96-well filter plates in combination with the 
UniVac 3 vacuum manifold were used to perform the parallel filtration of the ligand library. The 
hydrogenation reaction is carried out in a Premex 96-Multi Reactor3 that can accommodate 96 
reactions vessels at the same temperature and hydrogen pressure or in the EndeavorTM4. 
31P NMR spectra were recorded at room temperature in dry undeuterated toluene on a Bruker 
Avance 300 (300MHz).  
Conversion and enantiomeric excesses were determined by capillary GC analysis with a CP-
Chirasil-L-Val (25m, 0.25mm, 0.12µm, 175°C) for reaction with substrate (1) and a CP-Chirasil-
Dex-CB column (25m, 0.25mm, 0.25µm, 140°C) for reaction with substrate (2). 
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Library Synthesis and Screening in Hydrogenation of (1) and (2). 
  
Stock solutions: Stock solutions were prepared by dissolving the proper amounts of every reagent 
necessary for the library synthesis in dry toluene (see Table 1). 
 





# Position Name CAS # Conc. [M]
(R)-O,O’-(1,1’-Dinaphtyl-2,2’-diyl)-phosphorus chloride 0.150
Triethylamine 0.505
1 1A Butylamine 109-73-9 0.152
2 1B Isopropylamine 75-31-0 0.145
3 1C Ter-butylamine 75-64-9 0.155
4 1D 3,3-dimethylbutylamine 15673-00-4 0.158
5 2A n-Nonylamine 112-20-9 0.159
6 2B Cyclohexylamine 108-91-8 0.154
7 2C 1-adamantanamine 768-94-5 0.154
8 2D Geranylamine 6246-48-6 0.161
9 3A Aniline 62-53-3 0.165
10 3B Ethyl nipecotate 71962-74-8 0.155
11 3C 4-nitroaniline 100-01-6 0.150
12 3D 2-ethylaniline 578-54-1 0.156
13 4A 2-aminopyridine 504-29-0 0.154
14 4B 2-aminomethylpyridine 3731-51-9 0.162
15 4C 2-(2-aminoethyl)pyridine 2706-56-1 0.159
16 4D 2-aminobiphenyl 90-41-5 0.157
17 5A Benzylamine 100-46-9 0.157
18 5B 1-naphthalenemethylamine 118-31-0 0.147
19 5C Aminodiphenylmethane 91-00-9 0.159
20 5D 2-methoxyethylamine 109-85-3 0.157
21 6A Aminoacetaldehyde, dimethyl acetal 22483-09-6 0.157
22 6B N,N-diethylethylenediamine 100-36-7 0.151
23 6C 1-(2-aminoethyl)piperidine 27578-60-5 0.157
24 6D 1-aminopiperidine 2213-43-6 0.160
25 7A Diethylamine 109-89-7 0.176
26 7B Piperidine 110-89-4 0.151
27 7C N-methyl-tertbutylamine 14610-37-8 0.158
28 7D (S)-(-)-1-methylbenzylamine 2627-86-3 0.161
29 8A Methyl isonipecotate 2971-79-1 0.164
30 8B e-caprolactam 105-60-2 0.157
31 8C Carbazole 86-74-8 0.159
32 8D Heptamethyleneimine 1121-92-2 0.150
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Ligand Synthesis: 0.333mL of the chlorophosphite solution was transferred into 32 wells of the 
Whatman PKP filter plate. 0.1mL of the triethylamine solution was added to each well. 0.333mL 
of each of the 32 amines solution was added to each of the 32 vials (see Table 2). The microplate 
was placed on an orbital shaker and vortexed for 2 hours. The microplate was then placed onto 
the vacuum manifold and filtration was performed upon application of the vacuum. The filtrates, 
i.e. 32 solutions of different phosphoramidites (0.766mL, concentration=0.065M) were collected 
and stored into a 96-well polypropylene microplate. 
 
Table 2. Volume of stock solutions used in the synthesis of the 32 ligands. 
 
31P NMR analysis: The 31P NMR spectra of library members # 3A, 1B, 4B, 7B, 4C, 6C, 6D, 7D 
were recorded in undeuterated toluene. No reference was used. In parenthesis, the relative areas 
of the peaks are given. 
 
31P-NMR (121MHz, 8H-toluene) of 3A: δ 148.1 (89), 141.9 (4), 136.5 (7). 1B: δ 152.1 (74), 142 
(12), 136.6 (14). 4B: δ 141.9, 136.5 (maj), 132.1, 32.6 (maj), 30.7, 28.9, 28.3, 26.7, 26. 7B: δ 
145.9 (89), 142 (4), 136.6 (7).  4C: δ 151.1 (87), 142 (3), 136.6 (7), 33.1 (3). 6C: δ 136.5 (50), 
33.3 (50).  6D: δ 145.8 (86), 141.9 (1), 136.5 (13). 7D: δ 152.4 (85), 141.9 (6), 136.5 (9). 
Based on the literature5, the peak at 136.5ppm can be attributed to the bis(1,1’-binaphthyl-2,2’-
ene)-pyrophosphite.  
  
Preparation of the catalytic mixture: A stock solution of the Rh precursor, Rh(COD)2BF4 was 
prepared in dry dichloromethane ([Rh]=0.0131M) as well as stock solutions for the two 







V (mL) mMol Ratio
PCl 0.333 0.0499 1
Et3N 0.1 0.0505 1.01
R1R2NH 0.333 0.0508 1.02
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The proper amount (see table 3) of the 32 ligand solutions was transferred from the microplate 
into two sets of 32 vials, equipped with stir bars. The toluene was left to evaporate overnight, as it 
was observed to have a negative effect on the catalyst. The Rh stock solution was then added to 
each of the 64 vials allowing the formation of two sets of 32 different catalysts. Solutions of the 
two substrates were then added respectively to each set, thus generating 64 catalytic mixtures, 
ready for hydrogenation (ratio Rh/ligand=2, ratio substrate/ligand=50, [Rh]=0.0015M). 
 
Hydrogenation: The catalytic mixtures were transferred under inert atmosphere to the parallel 
hydrogenation reactor. The vials were purged with hydrogen and put under a pressure of 6 bars. 
The reactions were left stirring at room temperature for an hour. The mixtures were then analyzed 
by chiral GC to determine the conversion and the e.e.. Absolute configuration was determined by 
comparison with reference compound. 
Conc. Volume mMol Ratio
[M] (mL) rel. to Rh
Rh 0.0131 0.25 0.0033 1
Ligand 0.0651 0.1 0.0065 1.98
Substrate 0.073 2.25 0.164 50
                                                                     S  5
Results 
Table 4. Conversion obtained during the hydrogenation of (1) and (2) with the library of ligands. 
 
 
Large-scale preparation of (R)-O,O’-(1,1’-Dinaphthyl-2,2’-diyl)-N-i-propylphosphorus amidite 
(L1B) 
# Position Substrate (1) Substrate (2)
Conv (%) e.e. of S (%) Conv (%) e.e. of S (%)
1 1A 100 78 29 65
2 1B 100 80 95 92
3 1C 100 80 99 92
4 1D 100 74 30 85
5 2A 100 75 18 50
6 2B 100 81 99 94
7 2C 100 84 65 9
8 2D 100 73 14 71
9 3A 100 82 25 37
10 3B 100 87 2 29
11 3C 100 73 2 21
12 3D 100 77 10 33
13 4A 100 75 59 1
14 4B 0 (-) 0 (-)
15 4C 0 (-) 0 (-)
16 4D 100 56 2 12
17 5A 100 78 28 73
18 5B 100 77 24 76
19 5C 100 65 72 96
20 5D 100 79 13 66
21 6A 100 82 30 64
22 6B 100 73 5 13
23 6C 5 70 0 (-)
24 6D 100 88 22 39
25 7A 100 94 11 41
26 7B 100 95 7 43
27 7C 100 91 13 34
28 7D 100 70 51 88
29 8A 100 92 8 26
30 8B 100 68 4 22
31 8C 100 63 2 25
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In the glove box, 587 mg of O,O’-(1,1’-Dinaphthyl-2,2’-diyl)-phosphorus chloride (1.68 mmol) 
was placed in a vial and dissolved in 2 mL of dry toluene. 3.15 mL of a 0.559 M solution of di-
ethylamine in toluene (1.76 mmol) and 3.49 mL of a 0.504 M solution of i-propylamine in 
toluene (1.76 mmol) were successively added to the chlorophosphite solution. After stirring for 2 
hours, the reaction mixture was filtered through a glass frit and the solids were washed with 10 
mL of toluene. The filtrates were collected and the solvent was removed under vacuum. The left-
over solids were dissolved in 5mL toluene and purified with a SiO2 column, previously treated 
with 1% solution of Et3N in toluene. After evaporation of the solvent, 387 mg of a white solid 
(1.04 mmol, 62% yield) was obtained. 1H NMR (Toluene d-8) δ: 7.63 (m, 4H), 7.42 (m, 4H), 
7.05 (m, 4H), 3.24 (m, 1H), 2.55 (t, J=8.6 Hz, 1H), 0.85 (dd, J=20.3, 6.3Hz, 6H); 13C NMR δ: 
26.33 (d, J=4.6 Hz, CH3), 27.10 (d, J=3.5 Hz, CH3), 43.48 (d, J=20.7 Hz, CH), 122.62 (d), 
123.32 (d), 124.54/124.57 (s), 125/125.08 (s), 125.27 (d), 126.75 (d), 126.8 (d), 127.68 (d), 
127.73 (d), 128.93 (d), 129.07 (d), 129.98 (d), 130.97 (d), 131.78 (s), 132.25 (s), 133.79 (s), 
133.85 (s), 149.11/149.17 (s), 150.71 (s); 31P NMR δ: 152.2 
 
 
Hydrogenation with  purified ligand: 
 
Several members of the library based on amines 7A, 1B, 7B, and 7D already prepared via the 
conventional procedure were used in hydrogenation of the two substrates for comparison 
purposes. For each ligands, the catalyst was preformed by mixing 8.1 mg of the Rh precursor, 
Rh(COD)2BF4 (2 mmol) with two equivalents of the ligand in 1 mL of dry DCM, under inert 
atmosphere. The reaction mixture was stirred for two hours and 0.5 mL of each of the 4 reaction 
mixtures was transferred twice into two different vessels of the Endeavor apparatus, thus filling 
the eight available vessels. The reactors were then purged with 5 low pressure/high pressure N2 
cycles. 5 mL of a 0.202 M stock solution of (1) in dry DCM was added to each of the first four 
vessels. 5 mL of a 0.2 M stock solution of (2) in dry isopropanol was added to each of the 
remaining four vessels (cf. Table 5). 5 low pressure/high pressure H2 cycles were applied to the 
reactors. The H2 pressure was then set at 5 bars and the reaction mixtures were stirred at 500 rpm. 
The hydrogen uptake was monitored during the course of the reaction. After 30 minutes, the 
reactors were opened and samples were taken and subjected after dilution to conversion and e.e. 
determination by GC (cf. Table 6). 
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Table 5. Endeavour Layout 
Vessels 1 2 3 4 5 6 7 8 
Rh(COD)2BF4 2 mmol 2 mmol 2 mmol 2 mmol 2 mmol 2 mmol 2 mmol 2 mmol 
Ligand 7A 7B 7D 1B 7A 7B 7D 1B 
Ligand/Rh 2 2 2 2 2 2 2 2 
Substrate (1) (1) (1) (1) (2) (2) (2) (2) 
Sub/Rh 100 100 100 100 100 100 100 100 
 
 
Table 6. Results of the Endeavour run and comparisons with the results obtained with the same 
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Vessel Ligand L Ref. Sub Conv (%) e.e. of S (%) Conv (%) e.e. of S (%)
1 NEt2 A7 (1) 100 97 100 94
2 Piperidyl B7 (1) 100 99 100 95
3 NHMeBenz D7 (1) 100 73 100 70
4 NHiPr B1 (1) 100 81 100 80
5 NEt2 A7 (2) 8 46 11 41
6 Piperidyl B7 (2) 11 55 7 43
7 NHMeBenz D7 (2) 96 94 51 88
8 NHiPr B1 (2) 100 95 95 92
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